"Designing Growth Strategies is in our DNA"
In April 2015, a US-based subsidiary of Asahi Kasei Corporation, Asahi Kasei Bioprocess America started a customer training program for virus filtration, fluid management, and bioprocessing in their newly established Massachusetts Training Center. Virus filtration technology is extensively used in the purification of biopharmaceutical products. Unlike small molecules, biological drugs are formulated by using a mixture of animal, plants, and synthetic sources.
Therefore, there are potential chances of viral contamination. There are certain types of viruses commonly encountered while conducting research, such as Mouse Minute Virus, Cache Valley Virus, Reovirus, and others. Additionally, certain practices such as poor manufacturing processes, poor handling, and lack of safety measures are lead to viral contamination in biopharmaceutical products.
To gain extensive insights into the market, Request for Customization
The global virus filtration market growth is being driven by increasing manufacturing of biologics and biopharmaceutical products. Moreover, the growing emphasis on implementation of safety measures is anticipated to drive the virus filtration market during the forecast period.
However, stringent government regulations and variation in regulatory laws enforced by government authorities are expected to hamper the growth of the global virus filtration market by 2026.
Some of the major companies covered in the global virus filtration market report are Asahi Kasei Medical Co. Ltd., General Electric Company, Danaher Corporation, Sartorius AG, Clean Cell Inc., Wuxi Biologics, Thermo Fischer Scientific Inc., Lonza Group Ltd, Charles River Laboratories International Inc., and others.
SEGMENTATION | DETAILS |
By Product | · Consumables - Kits and reagents - Others · Instruments - Filtration systems - Chromatography systems · Services |
By Application | · Biologicals · Medical devices · Water Purification · Air Filtration · Others |
By End-User | · Hospitals and Clinics · Pharmaceutical Companies · Medical Device Companies · Contract Testing Organizations · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
As per current market trends, biological application segment is expected to hold a significant share of the market. Rapidly increasing FDA approvals for biological products coupled with the gradual shift of preference towards biologics is projected to lead biologic application segment during the forecast period.
Based on the region, the global virus filtration market is segmented as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global virus filtration market owing to increased adoption of virus filters in medical as well as biopharmaceutical products manufacturing. In Europe, the virus filtration market is expected to witness huge growth owing to a growing number of research activities. The Asia Pacific and Latin America hold huge potential for the growth of the virus filtration market owing to increased adoption of virus filters for purification of air and water. Moreover, developing healthcare infrastructure in the Asia Pacific is expected to boost the production of biological products, which will eventually boost the adoption of virus filters during the forecast period.
US +1 833 909 2966 ( Toll Free )